Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Health Catalyst, Inc.HCAT · Entity 1565 | General Counsel | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Health Catalyst, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 351,372 |
Reported balance
After 2026-09-01 transaction · row 1
1 source rowRow 1 · 2026-09-01 · Tax withholding · Disposed 13,167 · Balance 351,372 F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 01, 2026 Filed Sep 3, 2026 20:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 13,167 | $1.70 | $22,431.30 |
DisclosureSEC source: 0001975281-26-000004 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 351,372 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 23:45 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 13,779 | $1.37 | $18,879.99 |
DisclosureSEC source: 0001975281-26-000003 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,539 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 02, 2026 Filed Mar 5, 2026 23:48 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 20,838 | $1.66 | $34,589.00 |
DisclosureSEC source: 0001975281-26-000002 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 378,318 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 26, 2026 Filed Feb 27, 2026 21:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 6,317 | $1.75 | $11,040.85 |
DisclosureSEC source: 0001975281-26-000001 · primarydocument.xml · nonDerivative · entry 3 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 399,156 F3 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 16,473 | $0.00 | $0.00 |
DisclosureSEC source: 0001975281-26-000001 · primarydocument.xml · nonDerivative · entry 2 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,473 F2 · shares: Represents an award of 16,473 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 21:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 289,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001975281-26-000001 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,000 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will vest in 12 equal quarterly installments beginning on March 1st 2026. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 23:37 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 27,425 | $2.64 | $72,327.95 |
DisclosureSEC source: 0001975281-25-000003 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,000 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2025 in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:20 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 14,387 | $2.90 | $41,725.18 |
DisclosureSEC source: 0001975281-25-000002 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,425 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 05, 2025 Filed Sep 9, 2025 20:19 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 6,175 | $3.35 | $20,704.78 |
DisclosureSEC source: 0001562180-25-006142 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,812 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2025 in accordance with Rule 10b5-1. Read SEC document |
| September 02, 2025 Filed Sep 4, 2025 22:33 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 3,138 | $3.36 | $10,552.15 |
DisclosureSEC source: 0001562180-25-006099 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,987 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 20:18 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 6,057 | $3.94 | $23,890.63 |
DisclosureSEC source: 0001562180-25-004632 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 151,125 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2025 in accordance with Rule 10b5-1. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 01:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 3,255 | $3.63 | $11,831.27 |
DisclosureSEC source: 0001562180-25-004394 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 157,182 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:16 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 13,827 | $4.55 | $62,860.31 |
DisclosureSEC source: 0001562180-25-002255 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 160,437 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2024 in accordance with Rule 10b5-1. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 22:21 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 9,024 | $4.58 | $41,303.75 |
DisclosureSEC source: 0001562180-25-002008 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,264 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 20, 2025 Filed Feb 25, 2025 01:49 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 13,538 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001549 · primarydocument.xml · nonDerivative · entry 2 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,288 F2 · shares: Represents an award of 13,538 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 20, 2025 Filed Feb 25, 2025 01:49 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 97,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-001549 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,750 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments. Read SEC document |
| January 06, 2025 Filed Jan 10, 2025 21:17 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,500 | $7.52 | $18,795.50 |
DisclosureSEC source: 0001562180-25-000314 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,250 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2024 in accordance with Rule 10b5-1. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 22:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 19,268 | $8.32 | $160,294.35 |
DisclosureSEC source: 0001562180-24-008306 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 72,250 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2024 in accordance with Rule 10b5-1. Read SEC document |
| December 01, 2024 Filed Dec 3, 2024 21:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 9,419 | $8.97 | $84,518.57 |
DisclosureSEC source: 0001562180-24-008096 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,518 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 22:06 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,466 | $7.39 | $18,221.52 |
DisclosureSEC source: 0001562180-24-006762 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 100,937 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2024 in accordance with Rule 10b5-1. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:42 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,222 | $7.27 | $8,882.84 |
DisclosureSEC source: 0001562180-24-006688 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,403 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| June 06, 2024 Filed Jun 12, 2024 20:25 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 2,387 | $6.71 | $16,017.96 |
DisclosureSEC source: 0001562180-24-004991 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 104,625 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2024 in accordance with Rule 10b5-1. Read SEC document |
| June 03, 2024 Filed Jun 4, 2024 20:13 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 1,300 | $6.53 | $8,493.29 |
DisclosureSEC source: 0001562180-24-004627 · primarydocument.xml · nonDerivative · entry 2 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,012 F2 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 31, 2024 Filed Jun 4, 2024 20:13 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 12,577 | $6.61 | $83,132.71 |
DisclosureSEC source: 0001562180-24-004627 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,312 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 1st, 2024 in accordance with Rule 10b5-1. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 21:14 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 3,315 | $8.05 | $26,689.73 |
DisclosureSEC source: 0001562180-24-002255 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,889 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 00:34 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 4,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001655 · primarydocument.xml · nonDerivative · entry 2 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,204 F2 · shares: Represents an award of 4,444 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 20, 2024 Filed Feb 23, 2024 00:34 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-001655 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,760 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:38 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 3,427 | $7.45 | $25,532.18 |
DisclosureSEC source: 0001562180-23-008135 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,760 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| October 05, 2023 Filed Oct 6, 2023 21:32 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-007244 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,187 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Read SEC document |
| September 06, 2023 Filed Sep 7, 2023 00:48 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,157 | $11.52 | $13,332.23 |
DisclosureSEC source: 0001562180-23-006768 · primarydocument.xml · nonDerivative · entry 2 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,187 F2 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 13, 2022 in accordance with Rule 10b5-1. Read SEC document |
| September 01, 2023 Filed Sep 7, 2023 00:48 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 500 | $11.78 | $5,888.25 |
DisclosureSEC source: 0001562180-23-006768 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,344 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| July 07, 2023 Filed Jul 11, 2023 20:05 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,179 | $11.14 | $13,134.06 |
DisclosureSEC source: 0001562180-23-005850 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,844 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 13, 2022 in accordance with Rule 10b5-1. F2 · balance_after: Includes 1,179 shares purchased under the Issuer's employee stock purchase plan on June 30, 2023. Read SEC document |
| June 06, 2023 Filed Jun 8, 2023 21:26 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | SaleCommon Stock | 1,078 | $11.84 | $12,763.52 |
DisclosureSEC source: 0001562180-23-004992 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,844 F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 13, 2022 in accordance with Rule 10b5-1. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 23:31 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | Tax withholdingCommon Stock | 577 | $11.24 | $6,484.90 |
DisclosureSEC source: 0001562180-23-004856 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,922 F1 · kind: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| May 03, 2023 Filed May 4, 2023 21:03 UTC | Health Catalyst, Inc. HCAT · Entity 1565 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-003936 · primarydocument.xml · nonDerivative · entry 1 Landry Benjamin · CIK 0001975281 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,499 F1 · shares: Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 25% of the RSUs will vest on December 1, 2023 and, thereafter, the remaining 75% of the RSUs will vest in 12 equal quarterly installments. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.